Sana Biotechnology(US:SANA) Globenewswireยท2025-08-26 20:05Core Viewpoint - Sana Biotechnology, Inc. is set to present at four investor conferences in September 2025, providing a business overview and updates on its engineered cell therapies [1][5]. Company Overview - Sana Biotechnology focuses on creating engineered cells as medicines, aiming to repair and control genes, and replace missing or damaged cells [3]. - The company operates in Seattle, WA, Cambridge, MA, and South San Francisco, CA [3]. Upcoming Events - Sana will present at the following conferences: - Citi's 2025 Biopharma Back-to-School Conference on September 2, 2025, at 3:15 p.m. ET [5]. - 2025 Wells Fargo Healthcare Conference on September 4, 2025, at 8:00 a.m. ET [5]. - Morgan Stanley 23 Annual Global Healthcare Conference on September 8, 2025, at 11:30 a.m. ET [5]. - HC Wainwright 27 Annual Global Investment Conference on September 9, 2025, at 9:30 a.m. ET [5]. Investor Relations - Webcasts of the presentations will be available on the Investor Relations page of Sana's website, with replays accessible for 30 days post-conference [2].